Tradeoffs Race to the Bottom: Where's the Cavalry?
Sep 26, 2024
Christine Baeder, President of Apotex USA, Alfred Engelberg, a retired attorney with a focus on the generic pharmaceutical industry, and Jeremy Greene, a professor at Johns Hopkins, dive into the rising costs of life-saving medications. They discuss the emotional toll on patients facing exorbitant prices and the struggles generics face against patent-holding brand companies. The conversation also covers the implications of recent reforms like the Inflation Reduction Act and the ongoing challenges of ensuring affordable medication access for all.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 3min
The High Cost of Life-Saving Medications
03:05 • 7min
Challenges in the Generic Drug Market
09:48 • 5min
Challenges in the Generics and Biosimilars Market
14:54 • 5min
Reforming Drug Pricing: The Impact of the Inflation Reduction Act
19:53 • 7min
Innovative Solutions in Addressing Stimulant Overdoses
27:22 • 4min